Mobile-health Network Solutions Class A (MNDR)
Connects Southeast Asian patients and providers through telehealth, clinic software, benefits and health commerce.
Something off on this page? Send us feedback.
Provides MaNaDr teleconsultation and care navigation, MaNaCare employer benefits, clinic software, and medicine and health-product commerce. Most revenue comes from private telemedicine, with the company acting as principal in patient consultations while also operating wholesale and marketplace channels.
Connects patients, doctors, clinics, employers, pharmacies and product vendors through the MaNaDr digital-health ecosystem, spanning teleconsultation, care navigation, clinic software, employee benefits and health-commerce workflows.
Earns most revenue from private telemedicine, setting patient consultation fees, paying contracted providers and recognizing transactions gross. MaNaPharma supplies clinics, while MaNaShop and MaNaStore combine owned-inventory sales with a third-party marketplace. Singapore remains the operating center, alongside teams and entities across Southeast Asia.
Relies on independent doctors, clinic-service providers and delivery partners, while healthcare, pharmacy, data-protection and product permissions govern the platform and associated businesses.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Dec 31, 2025Cash & short-term investments $2.7M · Total debt $95.7K · Total assets $7.7M · Shareholders' equity $6.5M
- Revenue
- $3.1M
- Operating income
- −$680.1K
- Net income
- −$665.5K
No dividends on record.
| Institutions3 holders · as of Mar 31, 2026 | 23.20% | 5.7K ADS | |
| Otherremainder | 76.80% | 18.9K ADS |
24.6K ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Jun 2025 annual report; nothing newer is on file here.
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Virtu Financial LLCInstitution | 17.81% | 26,295 ADS | 13Fas of Mar 31, 2026 |
UBS Group AGInstitution | 5.36% | 7,912 ADS | 13Fas of Mar 31, 2026 |
Sbi Securities Co., Ltd.Institution | 0.03% | 41 ADS | 13Fas of Mar 31, 2026 |
Indopacific Health Investment Corporation Pte. Ltd.Institution | —6.43% of class, as filed | — | 13Dfiled Dec 4, 2025 ↗ |
Aik Huat Leong1Insiderofficer: Chief Financial Officer | — | — | Form 4filed Mar 19, 2026 ↗ |
| See all 8 → | |||
- This position is filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report
Insider tradesForm 4
No open-market trades in the last 12 months.
Not reported.